再组合甲氨酶协同逆转骨髓肉瘤细胞中发展的高多克萨抗性
Sei Morinaga1,2,3, Qinghong Han1, Kohei Mizuta1,2
1AntiCancer Inc., San Diego, CA, U.S.A.
Anticancer research
|October 30, 2024
概括
再组合甲胺酶 (rMETase) 在试验室中逆转了骨髓瘤细胞中的多塞素耐药性. 这种酶显示出在患有骨髓瘤的患者中克服多塞塔塞尔耐药性的潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 多塞塔克塞尔和吉姆奇塔宾被用作骨髓瘤的二线治疗.
- 多塞塔克塞尔耐药性限制了这种治疗的有效性.
- 再组合甲氨酶 (rMETase) 正在作为克服这种耐药性的方法进行研究.
研究的目的:
- 为了确定rMETase是否可以逆转骨髓瘤细胞中的多塞素耐药性.
- 为了评估rMETase与多塞塔克塞尔结合的疗效.
主要方法:
- 开发出了耐多塞尔的143B (DTR-143B) 骨肉瘤细胞.
- 确定了多塞塔塞尔和rMETase的50%抑制度 (IC50) 对于父细胞和耐药细胞.
- 在体外实验中,比较了单独使用多塞塔塞尔,单独使用rMETase和它们的组合.
主要成果:
- 与父细胞相比,dcetaxel耐药细胞的IC50为dcetaxel的7倍.
- rMETase和dcetaxel的组合抑制了DTR-143B细胞73.7%,明显超过单独使用的任何一种药物.
- rMETase在耐多塞塔塞尔骨髓瘤细胞中增加了多塞塔塞尔疗效的10倍.
结论:
- 在实验室中,rMETase有效地逆转了骨髓瘤细胞中的多塞素耐药性.
- rMETase在骨髓瘤患者中证明了克服多塞素耐药性的临床潜力.
更多相关视频
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
13.3K
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.2K
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
